Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
6/20/24 Gilead Sciences (GILD) Sunlenca for HIV Prevention Subscribers Only Subscribers Only Subscribers Only
6/18/24 Intra-Cellular Therapies (ITCI) Caplyta for Major Depressive Disorder (MDD) Subscribers Only Subscribers Only Subscribers Only
6/17/24 Takeda Pharmaceutical (TAK) Soticlestat for Lennox-Gastaut Syndrome (LGS; Epilepsy) Subscribers Only Subscribers Only Subscribers Only
6/17/24 Takeda Pharmaceutical (TAK) Soticlestat for Dravet Syndrome (Epilepsy) Subscribers Only Subscribers Only Subscribers Only
6/17/24 Marinus (MRNS) Ztalmy for Seizure Disorders (Epilepsy) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
02/29/24 Subscribers Only Subscribers Only Trial Data - Top-Line Results
03/19/24 Subscribers Only Subscribers Only Company - Analyst/R&D Update
04/09/24 Subscribers Only Subscribers Only Company - Analyst/R&D Update
04/18/24 Subscribers Only Subscribers Only Company - Analyst/R&D Update
05/03/24 Subscribers Only Subscribers Only Partnership - Acquisition Completion